Pyxis Oncology (PYXS) Tax Provisions (2024 - 2025)
Pyxis Oncology (PYXS) reported Tax Provisions of $1.1 million for Q4 2025, up 151.62% year-over-year from $443928.0 in Q4 2024, and up 151.62% quarter-over-quarter from -$2.2 million in Q4 2024.
Pyxis Oncology (PYXS) Tax Provisions (2024 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 2 years of Tax Provisions data on file, last reported at $1.1 million in Q4 2025.
- Tax Provisions for Q4 2025 came in at $1.1 million, up 151.62% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.0 million (changed N/A YoY), and the FY2025 annual result was $1.4 million, up 164.7% from the prior year.
- Tax Provisions improved to $1.1 million in Q4 2025 per PYXS's latest filing, from -$2.2 million in the prior quarter.
- Over five years, Tax Provisions peaked at $1.1 million in Q4 2025 and troughed at -$2.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Pyxis Oncology | 125.84 Mn | 108.95 Mn | 8.65 Mn | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | -2.16 Mn |